Quanterix To Participate at The Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum

Rhea-AI Summary

Quanterix Corporation (NASDAQ: QTRX) Announces CEO's Participation in Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum. President and CEO Masoud Toloue will speak in a fireside chat on November 16, 2023, at 3:00 PM ET. The live webcast can be accessed by registering on the company's website, with a replay available afterward. This event aims to provide insights into the company's strategic direction and industry trends.

BILLERICA, Mass.--(BUSINESS WIRE)-- Quanterix Corporation (NASDAQ: QTRX), a company fueling scientific discovery through ultrasensitive biomarker detection, today announced that President and Chief Executive Officer Masoud Toloue will speak in a fireside chat at the Canaccord Genuity MedTech, Diagnostics and Digital Health & Services Forum on Thursday, November 16, 2023 at 3:00 PM ET. To access the live webcast, please register here. A replay will be available following the conference on Quanterix’s website here: ir.quanterix.com.

To learn more about Quanterix, visit www.quanterix.com/company/.To learn more about Quanterix’s Simoa® technology, visit: www.quanterix.com/simoa-technology/.

About Quanterix
From discovery to diagnostics, Quanterix’s ultrasensitive biomarker detection is fueling breakthroughs only made possible through its unparalleled sensitivity and flexibility. The Company’s Simoa® technology has delivered the gold standard for earlier biomarker detection in blood, serum or plasma, with the ability to quantify proteins that are far lower than the Limit of Quantification (LoQ) of conventional analog methods. Its industry-leading precision instruments, digital immunoassay technology and CLIA-certified Accelerator laboratory have supported research that advances disease understanding and management in neurology, oncology, immunology, cardiology and infectious disease. Quanterix has been a trusted partner of the scientific community for nearly two decades, powering research published in more than 2,000 peer-reviewed journals. Find additional information about the Billerica, Massachusetts-based company at https://www.quanterix.com or follow us on Twitter and LinkedIn.

View source version on businesswire.com: https://www.businesswire.com/news/home/20231113873684/en/

Media:

PAN Communications

Maya Nimnicht

510-334-6273

quanterix@pancomm.com

Investor Relations:

Ed Joyce

610-306-9917

ir@quanterix.com

Source: Quanterix Corporation

FAQ

When will Masoud Toloue speak at the Canaccord Genuity Forum?

Masoud Toloue will speak at the Canaccord Genuity Forum on November 16, 2023, at 3:00 PM ET.

How can I access the live webcast of the event?

The live webcast can be accessed by registering on Quanterix Corporation's website.

Where can I find the replay of the event?

A replay will be available on Quanterix's website following the conference.